Protalix BioTherapeutics, Inc. (DE)
IPOProtalix.com
Public · Carmiel, Israel · Founded 1993 · $52.6M raised
- Headquarters
- Carmiel
- Employees
- 51–200
- Founded
- 1993
- Business Model
- B2B
- Website
- protalix.com
- Total Funding
- $52.6M
- Last Round
- $43.7M Growth EquityMar 2020
- Rounds
- 3
- Type
- Public
About
Biopharmaceutical company developing recombinant therapeutic proteins using proprietary plant cell-based expression system for rare diseases.
Summary
Protalix BioTherapeutics, Inc. (DE) is a Biotech company based in Carmiel, Israel, founded in 1993. It has raised $52.6M in total across 3 rounds, most recently a $43.7M Growth Equity round in Mar 2020. Investors include Pontifax.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2020
Sign up to see all 4 rounds
Venture Round through Growth Equity — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/protalix-biotherapeutics-inc-de"><img src="https://indexed.vc/api/badge/company/protalix-biotherapeutics-inc-de" alt="Protalix BioTherapeutics, Inc. (DE) on Indexed.vc" width="260" height="76" /></a>